Delivery of molecular and cellular medicine to solid tumors

Rakesh K Jain1

  • 1Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Insights

Researchers are analyzing the physiological barriers that prevent cancer therapies from reaching tumors. Understanding these barriers could lead to new strategies for improved cancer detection and treatment.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Cancer Biology

Background:

  • Solid tumors present significant physiological barriers to drug delivery.
  • Therapeutic molecules and cells face challenges entering and navigating tumor microenvironments.

Purpose of the Study:

  • To experimentally and theoretically analyze the steps involved in reaching cancer cells.
  • To integrate findings into a unified theoretical framework for understanding tumor barriers.
  • To develop novel strategies for overcoming these barriers in cancer therapy.

Main Methods:

  • Experimental analysis of molecular and cellular transport within tumors.
  • Theoretical modeling of physiological barriers in solid tumors.
  • Development of integrated frameworks combining experimental and theoretical data.

Main Results:

  • Identified key impediments in tumor vascularization and interstitial penetration.
  • Quantified the impact of tumor physiology on therapeutic agent delivery.
  • Established a foundational understanding of tumor barrier dynamics.

Conclusions:

  • A comprehensive understanding of tumor barriers is crucial for effective cancer treatment.
  • Novel strategies can be developed by exploiting or overcoming identified physiological barriers.
  • This research advances approaches for improved cancer detection and therapeutic interventions.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160